The following short term parameters evaluating essentially genotoxic effects were considered: liver DNA alkaline fragmentation (DFI), morphological transformation i n hamster embryo cells (TPI), and mutagenicity in the Ames' test (MPI). The internal consistency of the carcinogenicity data (OPI) was rather high (r = 0.8). The correlation with OPI of DFI and MPI was statistically significant but rather modest, about 0.4-0.5. The best correlation between OPI and TPI was 0.65. This level of correlation was observed only when some kind of doseresponse relationship for transformation could be established. When comparisons were attempted for exactly the same 27 compounds for all three tests, a general decrease in predictability was observed. This could be mainly due to problems of representation of the ideal population of chemicals using small samples. The more general problem of the quantitative approach to the predictability of short term tests was also discussed.
INTRODUCTION
For about 8 years people have been working on a large scale with short term carcinogenicity tests (I) . It is expected that we should know when [for instance for which chemical classes) it is more convenient to use one test in place of another, what kind of previsions have to be made when there is positivity in a given test, or what to do when a mix of positive and negative results emerges from a battery of tests.
It could seem surprising, but 8 years after the large scale study of short term tests for the purpose of predicting carcinogenicity, when we are confronted with a qualitative positive result in a given short term test, we have no clear idea if we are dealing with a potent or a weak compound. Even more confusing is the situation when we are confronted with a mix of positive and negative Presented at the Second International Symposium Sponsored by the Universities of Sassari and Cagliary. Session V: "Kisk Assessment." October 12-15. 1983. Alghero. Italy. This Syniposiuin section will bc continued in Volume 12. Number
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results in a battery of tests. On the other hand, while the knowledge of the weight that we have to give to few very important tests has not progressed significantly, approximately 100 new short term tests have been reported (2) . It is not known if some of these new proposed tests are better than the most common tests or if they are more specific for a given class of chemical compounds. Thus, we are confronted with an enormous amount of work that was perhaps either redundant, or for which an appropriate use has not been found or for which it is not certain that use will be found in the future.
We suggest that at least a significant part of the unsettled situation about the appropriate use of short term tests is due mainly to one fact. With short term tests performed in vitro, as in the Ames' test with metabolic activation, the test conditions may appear removed from the in vivo situation: absence of absorption, distribution and excretion of the chemical, and only a small part of metabolism and catabolism of the target organ is conserved. Moreover, effects are compared TOXICOLOGIC PATHOLOGY between a single step process (as in mutagenesis) with the effects on a multistep process (as in carcinogenesis).
Little was known concerning the relevance of the end points evaluated in different short term tests in respect to one or more of the steps in carcinogenesis. As a consequence of the numerous confounding factors interposed between any given short term test and carcinogenesis, it seemed realistic to attempt to establish only a qualitative correlation between carcinogenicity and the results obtained in a given short term test.
With this approach a significant amount of information was lost and it became impossible to evaluate the uncertainty of a given prevision, or to have an idea on the usefulness of a given piece of information. The qualitative approach was an intuitive reaction to the wide separation between short term tests and carcinogenesis, and proponents of the qualitative approach may have not considered that a quantitative approach would not dismiss, but indeed measure, the degree of uncertainty accompanying the information obtained with a given type of short term test. Thus, the quantitative approach would not make the information apparently more useful than what it is, but it would indicate the large confidence limits of a given degree of response when the information obtained is very poor and not very useful.
Crucial to the difference between the qualitative and the quantitative approach is the fact that while intuitively we can easily understand that in a battery of tests more information is contained than in the result of a single test, with the qualitative approach we do not know how to extract the increased amount of information. With the quantitative approach, to take advantage of the increased amount of information contained in a battery of tests it is a relatively straightforward process (3). Therefore, the degree of uncertainty about the carcinogenic potency of a given compound can decrease from almost useless levels to more acceptable ones. In the process of utilizing these vast amounts of information, and establishing quantitative correlations, we are compelled to analyze and attempt to settle important problems that could be ignored in the framework of the qualitative approach.
The first of these problems is the evaluation of carcinogenic potency in rodents. This will bring us to a better analysis of the amount of information contained in this type of data, and to the effort needed to normalize data. As in the previous case of the quantitative correlation between short term tests and carcinogenic potency, risk assessment ,e'valuations are linked to the degree of quantitative correlation between carcinogenic potency in humans and carcinogenic potency in rodenrs. Considering that our information on this type of correlation is scanty (4), and that the correlation between humans and rodents is relatively loose, it follows that the confidence limits around predictions based on this type of correlation are very large, although it is important to have an estimation of the degree of uncertainty for establishing safety limits for humans exposed to a given chemical.
In this report we will limit ourselves to the problem of quantitative correlations between short term tests and carcinogenic potency. A relatively small group of compounds for which information on multiple tests and carcinogenic potency was available will be used to exemplify some of the methodological problems that have to be dealt with in order to establish quantitative correlations.
Short Term Tests Examined and Methods for Calculating Different Potencies
We considered three different short term tests that in the process of carcinogenesis relate to three events progressively closer to malignant transformation.
The first test, alkaline elution of rat liver DNA after treatment in vivo, is related to the first step in initiation (DNA darnage). The second test, the Ames' test, is based on general effects of DNA damage like point mutations. The third test, morphological transformation of hamster embryo cells, looks at events considered significant steps in the carcinogenic process in vitro. Methodological details about the above mentioned three short term tests can be found elsewhere While in terms of end points there is probably a progression from DNA damage to point mutations and to morphological transformation, the same progression toward in vivo carcinogenesis is not present in the three tests as far as metabolic activation is concerned. From this point of view the evaluation of DNA damage appears to be the best test, because it is directly evaluated after treat-ment in vivo. In consequence, the predictability of the three tests should be dependent on many factors: end point, metabolic activation, and the type of chemical class considered. In this respect, there is a relatively small number of chemicals available and it is likely that they will not be representative of the entire spectrum of chemicals.
For calculating carcinogenic potencies and potencies for the different short term tests we defined the following parameters: OPI = Oncogenic Potency Index; DFI = DNA Fragmentation Index; MPI = Mutagenic Potency Index and TPI = Transforming Potency Index.
Oncogenic Potency Index. It was defined according to the following formula:
according to Meselson and Russell IS), where I is the cumulative single risk incidence of tumors; t the time of exposure (time unit = 2 years); D the dose (in millimoles/kg/day) equivalent to the total dose divided for a 2 year exposure; n was empirically set equal to I , because no improvement of predictability could be observed with higher exponents. Values of I were calculated exactly according to the methods C, and sometimes D, as indicated by the above authors 18). When more than one study was found, only the first five available were considered. The arithmetic mean of different OPI values was utilized. We adopted the simplest computation because it was difficult to find a rationale for a different type of mean.
The data on long term assays of carcinogenicity were obtained from the literature (9-7 9). DNA Fragmentation Index. It was calculated according to the following formula:
where Kt is the elution rate constant per unit volume for treated samples and Kc the same for control samples. K is defined by the equation:
where Qv is the fraction of DNA remaining on the filter and V is the eluted volume in ml for filters of constant diameter [2.5 cm).
The data we utilized were referred to in vivo DNA damage in rat or mouse liver; they were partially from our laboratory ( Transforming Potency Index. It was calculated according to the following formula:
/pg/ml of the lowest\ -1 transforming dose molecular weight TPI = where TPI is the reciprocal of the concentration in millimoles of the lowest transforming dose. The TPIs utilized for our comparisons were obtained from Pienta (91) .
The reasons for the calculation of these formulas and boundary conditions for calculation of OPI were discussed in previous papers (3, 92, 93).
DISCUSSION
Data on oncogenic potency (OPI), alkaline elution rate (DFI), mutagenicity in the Ames test (MPI) and morphological transformation in hamster embryo cells (TPI) was obtained for 27 compounds. From these data, potencies were calculated according to the previously mentioned formulas and the results obtained were presented in Table I .
In previous investigations, a larger set of data was obtained for OPI, MPI and TPI only (94) and also a larger set of data was obtained for OPI, DFI and MPI only (93) .
The correlation values shown in Table I1 reveal clearly the kind of problems that are encountered going from larger sets (triplets of data) to smaller sets (quadruplets of data).
The predictability of DFI is halved going from 54 to 27 compounds and becomes absolutely insignificant for the smallest set of 'Log of 1 value; b~cd~*Log of the mean of 2, 3, 4, 5 values, respectively. 'All TPI values were obtained from Ref. (91) . 'For these compounds an inactive concentration was available in the transformation assay (i.e. some kind of dose-response relalionship could be established).
where carcinogenicity could not be predicted by the DFI test (81) . Another important discrepancy observed going from the larger sets of 59 and 32 compounds to the smaller subsets of 27 and 17 compounds is that the presence of a dose effect relationship seems to confer an improvement in predictability to the parameter TPI in the larger sets, while it is lost in the smaller subsets.
This discrepancy underlines the problem of representation of small samples in respect to the (difficult to define) entire population of chemicals. Another possibility is that variations observed in changing the size of the sets are related to the simple fact that the confidence limits for sizes of this order are indeed extremely large. From previous studies on the predictability of different short term tests, we observed that the correlation level most commonly found is r = 0.4. In   Figure 1 the 95% confidence limits for a correlation level r = 0.4 are shown for different sizes of the sets considered. Figure I suggests that we are faced with a dilemma. Relatively large sets can be obtained only considering all the compounds tested with a given short term test. On the other hand, this average level of correlation is probably not very sig-nificant, considering the non-homogeneous composition of the set and the fact that the predictability can change dramatically according to different chemical classes.
In conclusion, if only smaller homogeneous subsets in terms of chemical class can be considered legitimate, we will have to live with the fact that the uncertainty about the estimation of r will be very large. This obviously will complicate the problem of establishing confidence limits for a predicted carcinogenic potency. This complication will be present also when evaluating multiple correlations with a battery of short term tests.
The results shown in Table I1 lend themselves to further comment. Assuming that the correlation values observed for the quadruplet set of parameters were truly representative of the real situation, this case could be a good example of a bad battery of short term tests. The reasons are &fold. One of the tests (DFI) is too poorly predictive and the other two tests (MPI and TPI) are too strongly correlated between themselves. As we have previously shown, dealing with a battery of tests, the maximum improvement in predictability from a multiple correlation is obtained when the short term tests are adequately correlated at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from .' Data obtained from the values listed in with carcinogenicity and at the same time poorly correlated amongst themselves (3). In order to check the feasibility of a quantitative evaluation of carcinogenic potency, we performed some preliminary controls. We investigated the internal consistency of the OPI data obtained from different papers on carcinogenicity experiments in rats and mice. For this purpose, from a total of 91 compounds we collected 56 chemicals for which more than one paper was available and randomly made subsets of OPI values, where each OPI value was referred to one of the different 56 chemicals. The average internal correlation between subsets of OPIs so made was r = 0.77 (93). This result indicates the existence of an acceptable internal consistency of the OPI values we computed for our investigations.
Further, in order to study the possible dependence of the OPI values on the type of formula used for their calculation, we calculated the oncogenic potencies according to the formulas a), b), and c):
In the framework of our boundary conditions, we found the correlation between formula a and b to have a correlation coefficient r = 0.97 for 59 compounds (94) and between formula b and c the coefficient was r = 0.97, for 97 compounds (unpublished data). These results strongly suggest that the boundary conditions adopted were adequate for an objective evaluation of the oncogenic potencies. Also, in relative terms, the oncogenic potencies are independent of the type of formula used for their calculation. Obviously, using different formulas for calculation, Log OPI values will be different for a constant correct ion factor.
Finally, for a small (insufficient) group of 19 chemicals we established two subsets of OPI values referring to experiments performed only in rats or in mice. We found a correlation r = 0.76 (unpublished data). This represents, at least, a preliminary evidence of the adequacy of assembling together mice and rats bioassay data.
Further controls are obviously needed. For example, we are actually collecting data to C) OPI = I/D-IOOO.
at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from investigate on the adequacy of assembling together data on oncogenic potencies obtained from experiments performed in vivo by different routes of administration.
In conclusion, although our analysis is not exhaustive, the evidence obtained suggests that an objective evaluation of carcinogenic potencies in rodents is feasible. Carcinogenic potencies in rodents are the nodal point for correlations with carcinogenicity in humans and with short term tests.
When linear regression is applied to a given sample for extrapolating carcinogenic potency from short term test data, the major difficulty is to establish that the compound and the sample do belong to the same set. However, this difficulty is common even to the qualitative approach. Besides these difficulties, three major facts seem to emerge: 1) The quantitative predictability of a single test is largely insufficient: 2) A suitable battery of at least three tests can offer a significantly higher level of predictability. A correlation coefficient, r = 0.7 could even be achieved against a r = 0.8 for the internal consistency 28. I t 0 N, Hiasa 
